- Home
- PRAX vs BORR Comparison
PRAX vs BORR Comparison
Compare PRAX & BORR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRAX
- BORR
- Stock Information
- Founded
- PRAX 2015
- BORR 2016
- Country
- PRAX United States
- BORR Bermuda
- Employees
- PRAX N/A
- BORR N/A
- Industry
- PRAX Biotechnology: Pharmaceutical Preparations
- BORR Oil & Gas Production
- Sector
- PRAX Health Care
- BORR Energy
- Exchange
- PRAX Nasdaq
- BORR Nasdaq
- Market Cap
- PRAX 599.7M
- BORR 493.0M
- IPO Year
- PRAX 2020
- BORR 2019
- Fundamental
- Price
- PRAX $42.34
- BORR $2.08
- Analyst Decision
- PRAX Strong Buy
- BORR Buy
- Analyst Count
- PRAX 11
- BORR 1
- Target Price
- PRAX $114.73
- BORR $9.00
- AVG Volume (30 Days)
- PRAX 279.7K
- BORR 6.8M
- Earning Date
- PRAX 08-12-2025
- BORR 08-13-2025
- Dividend Yield
- PRAX N/A
- BORR 3.78%
- EPS Growth
- PRAX N/A
- BORR 10.54
- EPS
- PRAX N/A
- BORR 0.20
- Revenue
- PRAX $8,122,000.00
- BORR $993,200,000.00
- Revenue This Year
- PRAX N/A
- BORR $8.35
- Revenue Next Year
- PRAX $6,358.50
- BORR $6.39
- P/E Ratio
- PRAX N/A
- BORR $11.48
- Revenue Growth
- PRAX 270.02
- BORR 19.15
- 52 Week Low
- PRAX $26.70
- BORR $1.55
- 52 Week High
- PRAX $91.83
- BORR $7.09
- Technical
- Relative Strength Index (RSI)
- PRAX 54.36
- BORR 54.11
- Support Level
- PRAX $41.64
- BORR $2.14
- Resistance Level
- PRAX $44.99
- BORR $2.35
- Average True Range (ATR)
- PRAX 2.55
- BORR 0.14
- MACD
- PRAX -0.11
- BORR 0.02
- Stochastic Oscillator
- PRAX 51.07
- BORR 60.14
About PRAX Praxis Precision Medicines Inc.
Praxis Precision Medicines Inc is a clinical-stage biopharmaceutical company. The firm is engaged in translating genetic insights into the development of therapies for patients affected by central nervous system disorders characterized by a neuronal excitation-inhibition imbalance. The company has generated three clinical-stage product candidates, ulixacaltamide (formerly known as PRAX-944), vormatrigine (formerly known as PRAX-628), and relutrigine (formerly known as PRAX-562), as well as PRAX-020 which has been in-licensed by UCB Biopharma SRL, or UCB.
About BORR Borr Drilling Limited
Borr Drilling Ltd is a drilling contractor that owns and operates jack-up rigs of modern and high-specification designs providing drilling services to the oil and gas exploration and production industry. The company operates a fleet of around 16 jack-up drilling rigs. Geographically the activities are carried out through Norway.